Summary & Overview
CPT 27059: Extensive Pelvis/Hip Soft Tissue Tumor Resection, 5 cm or Larger
CPT code 27059 denotes an extensive surgical excision of a soft tissue tumor and surrounding tissues in the pelvis or hip region when the lesion measures 5 cm or greater. Nationally, this code captures high-complexity oncologic and reconstructive procedures that have implications for surgical resource use, perioperative care pathways, and facility-level scheduling. It is significant for hospitals, surgical centers, and payers because these procedures typically require multidisciplinary coordination, advanced perioperative planning, and potential inpatient recovery.
Key payers included in the discussion are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will gain a concise overview of the clinical context for use of CPT code 27059, including where the procedure is typically performed and the service type. The publication also outlines what to expect in related sections: national benchmark considerations for utilization, common billing modifiers and administrative notes (where available), and clinical factors that drive use of the code. Data not available in the input will be noted where applicable.
Billing Code Overview
CPT code 27059 describes extensive surgical removal of a soft tissue tumor and surrounding tissues of the pelvis and hip area measuring 5 cm or more. This procedure involves wide excision of a large soft tissue mass in the pelvic or proximal femoral region.
-
Service type: Major soft tissue tumor resection
-
Typical site of service: Inpatient or outpatient surgical setting, commonly performed in an operating room or ambulatory surgical center depending on patient condition and surgical complexity
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 62-year-old male presents with a progressively enlarging, firm, deep-seated soft tissue mass located in the left proximal thigh/pelvic girdle region. Preoperative magnetic resonance imaging demonstrates a well-defined 6.5 cm intramuscular mass abutting the iliopsoas and involving adjacent soft tissues without obvious distant metastasis. Core needle biopsy returns a high-grade soft tissue sarcoma. Multidisciplinary review (orthopedic oncology, surgical oncology, medical oncology, and radiation oncology) recommends wide local excision with negative margins.
The clinical workflow includes preoperative staging (imaging of the chest, abdomen, and pelvis as indicated), anesthesia evaluation, intraoperative tumor resection with en bloc removal of surrounding soft tissue and a margin of normal tissue, possible intraoperative frozen section margin assessment, placement of drains or reconstruction as required, and postoperative monitoring in PACU with planned pathology review for margin status. Postoperative care includes wound checks, pain control, and coordination with oncology for adjuvant therapy if indicated. Typical site of service is an inpatient or outpatient surgical center equipped for major soft tissue oncologic procedures of the pelvis/hip region.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when the procedure requires substantially greater work than typical (e.g., unusually extensive dissection, reconstruction). |